|
|
||||||||







Department of
*
Pathology and
Internal Medicine, Seoul National University College of Medicine, Seoul, Korea;
Institute of Allergy and Clinical Immunology, Seoul National University, Seoul, Korea;
Department of Pathology, Korea University College of Medicine, Seoul, Korea;
¶
Graduate School of Biotechnology, Korea University, Seoul, Korea;
|| Department of Diagnostic Pathology, Samsung Medical Center, Seoul, Korea;
#
Department of Pathology, Sungkyunkwan University College of Medicine, Suwon, Korea;
**
DiNonA, Suwon, Korea;

Department of Pathology, Kangwon National University College of Medicine, Chunchon, Korea; and
*
Department of Pathology, Hallym University College of Medicine, Chunchon, Korea
The down-regulation of surface expression of MHC class I molecules
has recently been reported in the CD99-deficient lymphoblastoid B cell
line displaying the characteristics of Hodgkins and Reed-Sternberg
phenotype. Here, we demonstrate that the reduction of MHC class I
molecules on the cell surface is primarily due to a defect in the
transport from the Golgi complex to the plasma membrane. Loss of CD99
did not affect the steady-state expression levels of mRNA and protein
of MHC class I molecules. In addition, the assembly of MHC class I
molecules and the transport from the endoplasmic reticulum to the
cis-Golgi occurred normally in the CD99-deficient cells,
and no difference was detected between the CD99-deficient and the
control cells in the pattern and degree of endocytosis. Instead, the
CD99-deficient cells displayed the delayed transport of newly
synthesized MHC class I molecules to the plasma membrane, thus causing
accumulation of the molecules within the cells. The accumulated MHC
class I molecules in the CD99-deficient cells were colocalized with
-mannosidase II and
-adaptin in the Golgi compartment. These
results suggest that CD99 may be associated with the post-Golgi
trafficking machinery by regulating the transport to the plasma
membrane rather than the endocytosis of surface MHC class I molecules,
providing a novel mechanism of MHC class I down-regulation for immune
escape.
This article has been cited by other articles:
![]() |
H.-J. Byun, I.-K. Hong, E. Kim, Y.-J. Jin, D.-I. Jeoung, J.-H. Hahn, Y.-M. Kim, S. H. Park, and H. Lee A Splice Variant of CD99 Increases Motility and MMP-9 Expression of Human Breast Cancer Cells through the AKT-, ERK-, and JNK-dependent AP-1 Activation Signaling Pathways J. Biol. Chem., November 17, 2006; 281(46): 34833 - 34847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jaksits, W. Bauer, E. Kriehuber, M. Zeyda, T. M. Stulnig, G. Stingl, E. Fiebiger, and D. Maurer Lipid Raft-Associated GTPase Signaling Controls Morphology and CD8+ T Cell Stimulatory Capacity of Human Dendritic Cells J. Immunol., August 1, 2004; 173(3): 1628 - 1639. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |